UNSPSC 51311602: Efletirizine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B6C301298G. European Medicines Agency schedules Efletirizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06467MIG. Efletirizine generally arises in the molecular formula C21H24F2N2O3.

UNSPSC 51311602 Efletirizine, a Commodity code, covers pharmaceutical products and drug formulations that state and local governments procure for public health, emergency response, and community health initiatives. Recent solicitation activity shows state and local buyers acquiring naloxone and related drug management systems to support overdose response and substance abuse prevention programs, rather than efletirizine specifically. The issuing bodies engaging under this code include county health departments and public health authorities managing community health services and emergency preparedness initiatives.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid response deadline was July 26, 2023. The contract terms include a two-year initial period with a one-year renewal option, fixed-fee pricing, E-Verify compliance, drug-free workplace certification, and specific insurance requirements. Vendors bear all shipping and delivery costs. The procurement does not specify set-aside designations for disadvantaged enterprises but introduces potential FEMA funding compliance requirements including adherence to environmental regulations. Recent activity is limited to this single identified opportunity in Florida; the code shows narrow current state and local procurement volume.